Atlas Trials

The Clinical Significance of Gut Permeability in Gastrointestinal Post Acute COVID-19 Syndrome

Clinical trial NCT05612087 · UNKNOWN

Trial details

NCT number
NCT05612087
Sponsor
Taipei Veterans General Hospital, Taiwan
Status
UNKNOWN
Study type
OBSERVATIONAL
Gastrointestinal Post Acute COVID-19 Syndrome
Start date
2022-11-08
Primary completion
2023-10-31
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.